And 2 of these stocks could still see double-digit upside over the next twelve months.
Read MoreThe tech- and pharma-centric Nasdaq index has certainly endured volatility recently, but there’s no denying it’s experienced a stunning overall rally this year. While it has dropped 6.1% over the last month to the lowest levels since March, it’s still up a strong 15% since the last close of 2018 and up 16.4% from the […]
Read MoreEDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive […]
Read MoreShares of Edwards Lifesciences Corp. (EW) surged on Monday after the medical device firm reported results from an important clinical trial. The stock posted one of its best days in history, rocketing to its highest level ever as a publicly traded company. Despite Monday’s news, the company’s gains may entice investors to overreact with enormous […]
Read MoreThe month of February is now in the bag, and investors have plenty of reasons to celebrate. Despite the Dow Jones Industrial Average closing slightly lower on Thursday for its third straight daily loss, the index still managed an 11.1% gain in February. That marks the best two-month beginning of a year since 1987 when […]
Read More